Table of Contents
What is the age range for the PHQ-9?
In which populations should the PHQ 2 and 9 tools be used? The PHQ 2 and 9 are appropriate to be used with individuals 12 years of age and older. The Severity Measure for Depression—Child Age 11–17 (adapted from PHQ-9 modified for Adolescents [PHQ-A]) is a 9- item measure that assesses the severity of depressive disorders and episodes (or clinically significant symptoms of depressive disorders and episodes) in children ages 11–17. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. PHQ-9 Depression Severity. Scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively. The Patient Health Questionnaire (PHQ)-9 is the major depressive disorder (MDD) module of the full PHQ. Used to provisionally diagnose depression and grade severity of symptoms in general medical and mental health settings. The Patient Health Questionnaire-9 (PHQ-9) is a self-rating scale for screening and assessing depression which covering the DSM-IV algorithm for major depression (18). Studies have proven the effectiveness of the PHQ-9 in screening depression (19–24) and its ability to monitor the severity of depression (25, 26).
What is the age range for PHQ 2?
This review identifies psychometric properties of the PHQ-2 for use as a depression screening among youth 12 years through 20 years of age. The purpose of the PHQ-2 is to provide a brief, initial screening for major depression. The PHQ-9 total score ranges from 0 to 27 (scores of 5–9 are classified as mild depression; 10–14 as moderate depression; 15–19 as moderately severe depression; ≥ 20 as severe depression) [30]. Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Validity has been assessed against an independent structured mental health professional (MHP) interview. PHQ-9 score ≥10 had a sensitivity of 88% and a specificity of 88% for major depression. The Patient Health Questionnaire (PHQ-15) is a somatic symptoms subscale derived from a self- administered version of the Primary Care Evaluation of Mental Disorders (PRIME-MD) diagnostic instrument for common mental disorders. The 9-question Patient Health Questionnaire (PHQ-9) is a diagnostic tool introduced in 2001 to screen adult patients in a primary care setting for the presence and severity of depression. To use the PHQ-9 to screen for suicide risk: All positive answers to question 9 as well as the two additional suicide items MUST be followed up by a clinical interview. To use the PHQ-9 to obtain a total score and assess depressive severity: Add up the numbers endorsed for questions 1-9 and obtain a total score.
What age is PHQ-2 for?
This review identifies psychometric properties of the PHQ-2 for use as a depression screening among youth 12 years through 20 years of age. The purpose of the PHQ-2 is to provide a brief, initial screening for major depression. PHQ-9 items reflect the 9 DSM symptoms of major depression; PHQ-2 items reflect depressed mood and anhedonia. We prioritized major depressive episode over major depressive disorder, if both were provided, because screening attempts to detect episodes, and we prioritized DSM over ICD. The ADRS is a useful, short, clinician-report and self-report scale to evaluate adolescent depression. Further studies to replicate our findings and evaluate ADRS sensitivity to effects of treatment and psychometric properties in populations of adolescents with several psychiatric disorders are warranted. Instead, major depression is a persistently sad or irritable mood that affects a child’s thinking and behavior at home, in school, and with peers. The National Institute of Mental Health estimates that more than 10 percent of adolescents ages 12-17 experience major depression in a given year.
What age is PHQ 2 for?
This review identifies psychometric properties of the PHQ-2 for use as a depression screening among youth 12 years through 20 years of age. The purpose of the PHQ-2 is to provide a brief, initial screening for major depression. Conclusion: The modified PHQ-12 item is a valid and reliable instrument for large scale population based screening of depression in Asian Indians and a cut point score of greater than 4 gave the highest sensitivity and specificity. PHQ-9 Score Interpretation Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression. The Patient Health Questionnaire – 9 (PHQ-9) and Generalized Anxiety Disorder – 7 (GAD-7) are short screening measures used in medical and community settings to assess depression and anxiety severity. For scoring, response options for these two symptoms are coded as 0 (“not at all”), 1 (“several days”), or 2 (“more than half the days” or “nearly every day”). Thus, the total PHQ-15 score ranges from 0 to 30 and scores of ≥5, ≥10, ≥15 represent mild, moderate and severe levels of somatization. The available data suggests that age three is the lowest threshold at which childhood depression appears, but that doesn’t mean it can’t be identified earlier or that there aren’t risk signs earlier.
What age is PHQ 15 for?
Adapted from Physical Symptoms (PHQ-15) for research and evaluation purposes. The DSM-5 Level 2 Measure—Somatic Symptom—Parent/Guardian of Child Age 6–17 is an adaptation of the 15-item Patient Health Questionnaire Physical Symptoms (PHQ-15) that assesses the domain of somatic symptoms. Description of Measure: The PHQ-9 and PHQ-2, components of the longer Patient Health Questionnaire, offer psychologists concise, self-administered tools for assessing depression. PHQ-9 Depression Severity. Scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively. Regarding severity, PHQ-9 comprises five categories, where a cut-off point of 0–4 indicates no depressive symptoms, 5–9 mild depressive symptoms, 10–14 moderate depressive symptoms, 15–19 moderately-severe depressive symptoms, and 20–27 severe depressive symptoms [25]. The PHQ-9, described above, is a 9-item self-report measure that assesses depression on a 4-point scale (from 0 = not at all to 3 = nearly every day). Total scores range from 0–27 with higher scores denoting a greater endorsement of depressive symptoms, and scores ≥ 10 indicating that a respondent may be depressed. The Patient Health Questionnaire—9 (PHQ-9) and the Generalized Anxiety Disorder Questionnaire– 7 (GAD-7) are short screening instruments used for detection of depression and anxiety symptoms in various settings, including general and mental health care as well as the general population. Fast and easy to use, the PTI App version of the PHQ9-Youth is an economical, reliable and validated method to screen and assess.
Is PHQ-9 validated in youth?
Fast and easy to use, the PTI App version of the PHQ9-Youth is an economical, reliable and validated method to screen and assess. The PHQ-9 should be administered at least quarterly after initial positive screen (defined as a score of 10 or greater). b. For enrollee/members scoring 5-9 on the PHQ-9, a repeat PHQ-9 should be completed as clinically indicated or at a minimum of at least annually. The PHQ-9 is intended as a tool to assist clinicians with identifying and diagnosing depression but is not a substitute for diagnosis by a trained clinician. This is used by some clinicians and organizations to screen patients for undiagnosed depression. The PHQ-2 consists of the first two questions asked on the PHQ-9.